Recode.net : Apple has a new TV show, so will it finally buy a big media company

Apple has a new TV show, so will it finally buy a big media company? No, says Eddy Cue.
“Planet of the Apps” is another way to sell more Apple Music subscriptions.


Apple now has a new TV show, a reality series showing app developers vying for new investment dollars. It’s called “Planet of the Apps.”

Kitschy.

The series was designed to promote Apple Music, since that’s where the show will be distributed, but it’s actually a way to differentiate Apple Music from Spotify. “Planet” was produced by Ben Silverman, a former co-chair of NBC Entertainment who was also behind hit shows like “Jane the Virgin” and the U.S. version of “The Office.”

So now that Apple is producing original content, Recode senior editor Peter Kafka asked Eddy Cue, Apple’s head of content, a key question at the Code Media conference at the Ritz-Carlton in Dana Point, Calif.: Will Apple finally just go ahead and buy a big film studio or media company like Sony Pictures or Time Warner or Netflix or Lionsgate?

Short answer: No.

But just in case you think there might be some wiggle room in there for some kind of acquisition later on, here’s a fuller version of his response:

We're trying to do things that are unique and cultural. ... We think we have a real opportunity in the TV space to do that with Apple Music and shows and the things we're trying to do aren't being done by anybody else. ... So yes, to the extent if we wanted to do what everybody else is doing, then you’re right, we might be better off buying somebody or doing that.

But that’s not what we're trying to do. We are trying to do something that’s unique, takes advantage of our platforms and that really brings culture to it. ... Right now we think we can do that with partners like Ben and we don’t see that anywhere else.
So there you have it.

Watch the full interview below.

WSJ : Toshiba’s Meltdown: Chairman Out, $6.3 Billion Write-Down

Toshiba’s Meltdown: Chairman Out, $6.3 Billion Write-Down
Company postpones issuing earnings results as it warns of large write-down on its nuclear business

TOKYO— Toshiba Corp.’s problems threatened to spiral out of control as the electronics giant projected a $6.3 billion write-down, postponed its earnings report because of allegations of impropriety and said its chairman was resigning—all in the space of a day.

The delay in the earnings report sent Toshiba shares down 8% in Tokyo trading Tuesday, and its president said he was willing to sell most or all of Toshiba’s profitable flash-memory business to help the company survive past the end of its fiscal year March 31.

The latest troubles stem from Toshiba’s U.S. nuclear plant business, Westinghouse Electric Co., which is battling cost overruns at reactor projects in Georgia and South Carolina.

The losses have gotten so big that they could topple a company whose roots go back to 1875, the dawn of Japan’s modern era. Known for its pioneering innovations in notebook computers and the flash memory chips that are ubiquitous in today’s devices, Toshiba has struggled in recent years with the decline of its consumer business.

A 2015 accounting scandal, in which the company acknowledged fudging numbers to make its personal computer business and other units look better, led to the resignations of top officials.

One of those who assumed a top role in the wake of the scandal was Chairman Shigenori Shiga, a longtime executive in Toshiba’s nuclear business. The company said Tuesday that Mr. Shiga would resign as chairman, effective Wednesday, and former Westinghouse Chief Executive Danny Roderick was stripped of his executive post at Toshiba headquarters.

“I apologize deeply for all the inconvenience we have caused our stakeholders,” Toshiba Chief Executive Satoshi Tsunakawa said at a news conference.


Toshiba’s willingness to sell a majority of its main remaining crown jewel, the memory-chip business that supplies smartphone makers such as Apple Inc., marked a drastic shift from its stance weeks ago when it said it would limit any buyer’s stake to 19.9%.

“The best possible option is to sell everything because it would be meaningless for Toshiba to keep a minority stake in the memory business,” said Ace Research Institute analyst Hideki Yasuda.
The company said its shareholder equity fell into negative territory as of Dec. 31, leaving just a month and a half to find ways to get back above zero before the March 31 fiscal year-end.

Toshiba had been scheduled to announce its April-December results at noon local time Tuesday, the final day for companies to release quarterly results under listing rules. But after that hour came and went with no release, Toshiba said it was asking for a one-month delay.

It said an internal whistleblower had raised suspicions that management at Westinghouse Electric had exerted inappropriate pressure over the unit’s accounting. It said a law firm hired by Toshiba had interviewed those involved in the issue and found inconsistencies in their stories.

Toshiba said it couldn’t release official results while the investigation continued. It didn’t give details about the alleged pressure.

Later Tuesday, Toshiba released a presentation containing many of the numbers that would normally go in an official results release including the ¥712.5 billion ($6.3 billion) write-down on the nuclear business.

Toshiba paid $5.4 billion for Westinghouse in 2006, anticipating a nuclear-power renaissance that never came. Stricter safety standards after the 2011 Fukushima nuclear accident in Japan added to the cost of plants in China and the U.S.

“Our acquisition of Westinghouse back then might not have been the right decision, if you consider the numbers today,” said Mr. Tsunakawa, the chief executive.

The company confirmed reports that it would stop building nuclear power plants and focus on selling reactor designs as well as nuclear services. Mr. Tsunakawa said Toshiba was willing to sell a majority stake in Westinghouse, but analysts said they doubted anyone would want to buy it.

Westinghouse is building reactors in Georgia and South Carolina commissioned by utilities Southern Co. and Scana Corp., respectively.

To end litigation over cost overruns, Westinghouse in 2015 made a deal to acquire Stone & Webster, its construction partner on the U.S. nuclear projects. Westinghouse and its parent became the only guarantor on the projects, meaning that if the reactors couldn’t be completed in a timely manner, Toshiba would shoulder the costs.

Toshiba provided some details Tuesday on the cost overruns, saying labor costs were expected to run $3.7 billion more than earlier calculations, while contractors and materials were responsible for $1.8 billion in cost overruns.

Toshiba said it based its latest cost calculations on the most pessimistic scenario, but executives also said they couldn’t rule out further losses. They said four nuclear plant projects in China were also behind schedule.

Investors said the turmoil left them uncertain whether Toshiba had a viable survival plan. “They are losing trust,” said Ichiro Yamada, general manager of the equities department at Fukoku Mutual Life Insurance Co.

Masayuki Kubota, chief strategist at Rakuten Securities, said that if the company continued to unload its most profitable businesses while keeping problem units, “it is impossible to have hope about Toshiba’s future.”

FT : Investors position for Trump growth boom over next 12 months

Investors position for Trump growth boom over next 12 months
BofA survey finds growing number of money managers expect an end to ‘secular stagnation’

Global investors are positioning themselves for a mini-economic boom over the next 12 months in another sign of revived animal spirits following the election of Donald Trump, according to a major survey of money managers.

Underscoring a sharp reversal in the prospects for the world economy, 23 per cent of investors surveyed by Bank of America Merrill Lynch said they expected above trend global growth and inflation over the next year, climbing from just 1 per cent during the same period in 2016.

Equity markets have been buoyed by the new White House administration’s promise to unleash major corporate tax cuts and bumper government spending, with Mr Trump’s election lifting the dollar, inflation expectations and short-run GDP forecasts in the world’s largest economy.

Of the 210 money managers surveyed, 43 per cent said they expected a continuation of “secular stagnation” over the next 12 months, dropping from 88 per cent over the same period in 2016. The term secular stagnation — revived and popularised by former US Treasury secretary Larry Summers since the financial crisis — has been used to describe a persistently low growth and low inflationary environment that has threatened to beset developed world economies since 2008.

In Europe, sentiment remained bullish but investors are increasingly eyeing a packed roster of major elections in the single currency area over the next six months. The threat of a “disintegration” of the EU project was cited as the single biggest “tail risk” facing investors this year, at 36 per cent, followed by risks of a global trade war at just under a third.

Bearish sentiment has been concentrated on France, a founding member of the EU, where rising Euroscepticism has spooked markets. Sentiment towards French stocks has fallen to its lowest level in nearly two years this month — making them the least loved asset class in Europe, said BofA.

The country’s main stock index, the CAC 40, is up just 0.6 per cent this year, underperforming its German rival the Dax (up 2.5 per cent) and the FTSE 100 (up 2 per cent) in 2017.

An unpredictable election race has also seen investors dump French bonds. While the far-right Marine Le Pen is seeking to take the country out of the eurozone, the erstwhile favourite for the job — centre-right François Fillon — has been engulfed in a family payments scandal this month. That has helped send the country’s benchmark 10-year bond yield, which reflects the government’s borrowing costs, from a record low of 0.1 per cent to more than 1 per cent since the autumn. Yields rise when bond prices fall.

Latest betting odds from Betfair show Ms Le Pen has a 69 per cent chance of winning the first round vote in late April, but will be beaten in the second round vote a week later regardless of her opponent.

BofA’s global survey was carried out between February 3-9, with investors reporting a total of $632bn in assets under management.

>>> US Gapping down


Gapping down
In reaction to disappointing earnings/guidance
:

  • HIBB -10.4%, (sees Q4 results below estimates, offers light FY18 guidance), AMKR -10.4%, RCII -6.4%, TTM -5.9%, VG -5.2%, NTWK -5.1%, RNG -4.6%
  • BKD -4.6%, TTS -3%, FLO -1.9%, DBD -1.8%, ACOR -1.6%, AGII -1.4%, TMUS -1.3%, INCY -1%, BRX -0.9%, CUTR -0.5%

M&A news:

  • PLKI -3.3% (Restaurant Brands (QSR) might have walked away from potential M&A deal with PLKI, according to NY Post), HOLX -2% (to acquire CYNO for $66 per share)

Other news:

  • AVIR -37% (announces top-line data from its Phase 2b SPIRITUS trial of Vapendavir; Vapendavir did not demonstrate a statistically significant reduction in the asthma control questionnaire-6 (ACQ-6) at day 14, the primary endpoint, for either the 264 mg or 528 mg cohorts compared to placebo)
  • GEVO -25.3% ( announces proposed public offering of common stock and warrants; announces that WB Gevo, Ltd., the holder of the Co's issued and outstanding 10% Convertible Senior Notes, due 2017, and the Co have agreed to extend the maturity date of the 2017 Notes from March 15, 2017 to June 23, 2017 )
  • ATOS -9.8% (files for $4 mln common stock offering )
  • BGFV -5.1% (following HIBB guidance)
  • GLNG -4.9% (to offer $350 million aggregate principal amount of Convertible Senior Notes )
  • PFLT -3.7% (plans to make a public offering of 5,000,000 shares of its common stock )
  • DNR -2.6% (reports year-end 2016 proved reserves and preliminary 2016 production)
  • FXCM -1.7% (issues statement on the settlement of the civil action filed by the Commodity FTC regarding the brief undercapitalization FXCM US suffered as the direct result of the Swiss National Bank; includes a fine of $650)
  • DKS -0.8% (following Hibbett Sporting guidance)

Analyst comments:

  • DEPO -1.5% (downgraded to Neutral at Mizuho)
  • USAC -1.4% (downgraded to Sector Perform at RBC)
  • NSP -1.2% (downgraded to Neutral at Roth)
  • JCI -0.5% (downgraded to Hold from Buy at Argus)

>>> US Gapping up


Gapping up
In reaction to strong earnings/guidance
:

  • RLOG +26.3%, CGA +23.9%, BLIN +17.9%, CDXC +10.7%, SALE +10.6%, KOOL +9.7%, (thinly traded), NVTA +9.2%, URRE +6.4%, PDFS +6%, CRL +4.3%
  • GUID +3.9%, CSOD +3.8%, QTNA +3.3%, NBL +2.4%, GILT +2%, NVMI +1.7%, FLIR +1.6%, GPOR +1.5%, SCI +1.5%, GNRC +1.4%, SMI +1.4%
  • CHGG +1.2%, BRKR +1.2%, CS +1%, OMF +0.8%, DSX +0.5%

M&A news:

  • GIG +12.9% (GigPeak to be acquired by Integrated Device Technology for $3.08/share, or approximately $250 mln)
  • GM +4.1% (Peugeot confirms it is exploring numerous strategic initiatives with GM, aiming at improving its profitability and operational efficiency, including a potential acquisition of Opel)
  • IDTI +3.4% (GigPeak to be acquired by Integrated Device Technology for $3.08/share, or approximately $250 mln)

Select metals/mining stocks trading higher:

  • FSM +4.6%, HMY +3%, SBGL +2.8%, KGC +2.5%, AU +1.4%, SLW +1.4%, IAG +1.3%, GOLD +1.3%, GG +1.2%, GDX +1.2%, MUX +1%

Select Dry Shipping related names showing continued strength:

  • SINO +16.6%, STNG +6.8%, DCIX +3.3%, DRYS +2.5%

Other news:

  • ZAIS +23.9% (thinly traded; higher after reporting estimated unaudited net performance returns for the month ended January and Christian Zugel active stake disclosure
  • CBIO +15.8% (provides update on its clinical development plans for its next-generation Factor VIIa and Factor IX candidates and reiterated its intention to commence two clinical trials in individuals with hemophilia B in 2017)
  • AXSM +12% (receives fast track designation from the FDA for AXS-05 for treatment resistant depression)
  • MRNS +11.2% (announces the publication of preclinical data in the January issue of Neuropharmacology)
  • AGEN +7% (Agenus & Incyte (INCY) amend license, development, & commercialization agreement; Agenus will receive accelerated milestone payments of $20 mln & a $60 mln equity investment)
  • TRXC +4.5% (announces first clinical use of Senhance Robotic Surgical System in France; now used to treat gynecologic cancer patients in France )
  • AUPH +4.1% (announces the results of a supportive Phase I safety, pharmacokinetic and pharmacodynamic study in healthy Japanese patients which supports further development of voclosporin in this patient population)
  • BLDP +3% (has joined consortium with New Flyer to deploy 20 zero-emission fuel cell electric buses in California )
  • IONS +2% (announces $75 mln from Bayer (BAYRY) for advancing IONIS-FXIRx and Ionis-FXI-Lrx)
  • GILD +1.4% (announces findings from new preclinical study evaluating novel class of HIV capsid inhibitors that support continued investigation; presents new phase 2 data on bictegravir)
  • CHK +1.3% (FY17 prod guidance and Cap-ex budget)
  • SHLD +1.1% (after declining another 8% on Monday)
  • F +1.1% (in sympathy with GM)

Analyst comments:

  • STNG +6.8% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
  • Z +2.4% (upgraded to Buy at Stifel)
  • VIP +2.3% (resumed with a Buy at Goldman)
  • CCJ +2.3% (upgraded to Outperform from Market Perform at BMO Capital Markets)
  • FRAC +1.8% (initiated with a Outperform at Wells Fargo; initiated with a Overweight at Morgan Stanley)
  • NE +1.5% (upgraded to Buy from Hold at Societe Generale)
  • UA +1.4% (upgraded to Equal-Weight from Underweight at Morgan Stanley)

>>> German Union on Peugeot / Opel

14 Feb - 14:17:57 RTRS - GERMAN UNION IG METALL, OPEL'S WORKS COUNCIL SAY TALKS BETWEEN GM GM.N AND PEUGEOT PEUP.PA OVER SALE OF OPEL WOULD BE UNPRECEDENTED BREACH OF GERMAN AND EUROPEAN CO-DETERMINATION RIGHTS
14 Feb - 14:18:39 RTRS - GERMAN UNION IG METALL, OPEL'S WORKS COUNCIL SAY IN JOINT STATEMENT THEY WOULD NONETHELESS EVALUATE ANY SALE OF OPEL TO PEUGEOT WITHOUT PREJUDICE